------------------------------------------------------------------------------------------------------------------ PDB NAME RESOLUTION NOTES KABAT LOOP LENGTHS CODE L1.L2.L3.H1.H2.H3 ------------------------------------------------------------------------------------------------------------------ 1ACY 59.1 3.0A/21% Complex with HIV-1 GP120 peptide 15.7.9.7.16.11 1AFV FAB25.3 3.70/21.70% Complex with HIV1 Capsid pretein P24 15.7.9.5.17.11 1AI1 FAB59.1 2.8/22% Complex with HIV-1 V3 Loop mimic (peptide) 15.7.9.7.16.11 1AIF 409.5.3 2.9/22.0% Anti-idiotypic (preliminary structure) 12.7.9.5.19.10 1AP2 C219 2.40/20.45% scFv 17.7.9.5.17.12 1BAF AN02 2.9A/19.5% Complex with DNP-spin-label 10.7.10.6.16.6 1BBD 8F5 2.8A/19% Anti-HRV2 17.7.9.5.17.9 1BBJ B72.3 3.1A/???? Human/mouse chimera (anti-protein) 11.7.9.5.17.5 1BJM LOC 2.2A/15.8% Human Bence-Jones xtals in sodium potassium sulphate 14.7.11 1BRE BRE 2.0A/21.8% Human light chain dimer 11.7.9 1CFV FV4155 2.1/24.7% Anti-steroid antibody 16.7.9.5.17.10 1CLO A5B7 2.1/21.2% Anti-Carcinoembryonic Antigen 10.7.9.5.19.10 1DBB DB3 2.7A/21.0% Complex with progesterone 16.7.9.5.17.10 1DFB 3D6 2.7A/17.7% Anti-HIV-GP41 11.7.7.5.17.17 1DVF E5.2/D1.3 1.9/19.4% Complex (Anti-idiotopic) E5.2 11.7.9.5.16.13 1EAP 17E8 2.5A/18.6% Complex with hapten (catalytic) 11.7.8.5.17.10 1FAI R19.9 2.7A/18.9% Anti-arsonate (Xtal 2) 11.7.9.5.17.15 1FBI F9.13.7 3.0A/19% Complex with guinea fowl lysozyme 11.7.9.5.17.13 1FGV H52 1.9A/18.0% Humanised anti-CD-18 (Some of H3 missing) 11.7.9.5.17.15 1FIG 1F7 3.0A/22.0% Complex with hapten (catalytic) 12.7.9.5.17.10 1FLR 4-4-20 1.85/18.8% Complex with fluorescein 16.7.9.5.19.7 1FOR Fab17-IA 2.75A/17.4% Anti-Human rhinovirus 10.7.9.5.17.10 1FPT C3 3.0A/23.0% Complex with Poliovirus Type 1 Peptide 16.7.9.5.17.11 1FRG 26-9 2.8A/19.0% Complex with hemagglutinin peptide 17.7.9.5.17.11 1FVC Hu-4D5 2.2A/18.3% Humanised 4D5 11.7.9.5.17.11 1FVD 4D5 2.5A/17.9% Humanized anti-P185(HER2) Variant 1 11.7.9.5.17.11 1GAF 48G7 1.95A/24.4% Complex (catalytic) with hapten 11.7.9.5.17.5 1GGI 50.1 2.8A/18.8% Complex with 16aa peptide HIV-1 GP120 15.7.9.7.16.5 1GHF GH1002 2.7/21.0% Anti-anti-idiotype Mouse Antibody 11.7.9.4.17.7 1GIG HC19 2.3A/19.5% Influenza virus hemagglutinin 14.7.9.5.16.14 1HCV 1HCV 1.85A/24.30% Llama HC anti-HCG alpha subunit 0.0.0.5.17.8 1HIL 17/9 2.0A/19% Anti-Flu HA peptide 17.7.9.5.17.11 1HYX 6D9 1.80/19.80% Catalytic complex with TS analogue 16.7.9.5.16.14 1IAI 730.1.4/409.5.3 2.9/21% Complex of Fab and anti-Id Fab 409.5.3 12.7.9.5.19.10 1IAI 730.1.4/409.5.3 2.9/21% Complex of Fab and anti-Id Fab 730.1.4 11.7.9.5.17.12 1IBG 40-50 2.7A/20.9% Complex with Ouabain 15.7.9.5.16.13 1IGC MOPC21 2.6A/16.8% ??? with Fc bound to Streptococcus Protein G Domain III 11.7.9.5.17.11 1IGF B13I2 2.8A/18% Anti-myohemerythrin peptide Fab-prime 16.7.9.5.17.10 1IGJ 26-10 2.5A/17.6% Complex with digoxin 16.7.9.5.17.10 1IGM HuIgM 2.3A/20.1% Human IgM Fv 11.7.9.5.17.12 1IGT MAB231 2.8/20.9% Intact antibody; IgG2A canine lymphoma 11.7.9.5.17.9 1IKF 1ikf 2.5A/16.4% Complex with Cyclosporin A 11.7.9.5.17.17 1IND CHA255 2.2A/18.8% Complex with indium(3+)-eotube (hapten) 14.7.9.5.17.5 1IVL M29B 2.17A/17.5% Light chain dimer 11.7.9 1JEL JE142 2.8A/19.3% Complex with histidine containing prot. 16.7.9.5.17.9 1JHL D11.15 2.4A/21.4% Complex with pheasant egg lysozyme 11.7.9.5.17.9 1KEL 28B4 1.9/19.9% Complex with Phosphonic Acid derivative. Catalytic 16.7.9.5.19.8 1LIL CLE 2.65/19% Bence-Jones 11.7.10 1LMK L5MK16 2.6A/20.0% Anti-phosphatidylinositol scFv 16.7.9.5.17.13 1LVE LEN 1.95A/16% Light chain monomer 17.7.9 1MAM YST9.1 2.5A/21.5% ?????? 11.7.9.5.19.8 1MCP McPC603 2.7A/22.5% Anti-PC 17.7.9.5.19.11 1MCW Weir/MCG 3.5A/17% Hybrid light chain dimer 14.7.10/14.7.10 1MEL CAB-LYS3 2.5/22.1% Complex of Camel single-domain VH with lysozyme /5.17.24 1MFA SE155-4 1.7A/16.6% Complex with trisaccharide (PDB ERROR!) 14.7.9.5.17.9 1MIM RFT5 2.6/19.6% Anti-CD25 10.7.7.5.17.8 1MLB D44.1 2.1A/18.1% Anti-hen egg lyzozyme (uncomplexed) 11.7.9.5.17.7 1MPA MN12H2 2.6/19.4% Complex with peptide from Neisseria Pora loop VR2 16.7.9.5.17.12 1MRE JEL103 2.3A/19.2% Complex with GDP 16.7.9.5.17.7 1NBV BV04-01 2.0A/24.6% Anti ss-DNA autoantibody 16.7.9.5.19.10 1NCB NC41 2.5A/16.5% Complex with neuraminidase N329D mutant 11.7.9.5.17.11 1NFD H57 2.80A/24.30% Complex with N15 T-cell receptor 11.7.11.5.19.9 1NGQ N1G9 2.4/19.4% Anti-(4-hydroxy-3-nitrophenyl)acetate Mouse Fab 14.7.9.5.17.11 1NLD FAB1583 2.9/19.8% Fab fragment against GP41 from HIV-1 16.7.9.5.16.5 1NMB NC10 2.5/21% Complex with N9 Neuraminidase 11.7.9.5.17.13 1NQB NQ11+B1-8 2.0/18.7% Trivalent antibody fragment (scFv) 16.7.9.5.17.11 1NSN N10 2.9/19.5% Complex with Staphylococcal nuclease 15.7.9.6.16.4 1OPG OPG2 2.0/16% Anti-receptor (Platelet Glycoprotein) 11.7.9.5.17.16 1OSP 184.1 1.95/22.9% Complex with Lipoprotein 11.7.9.5.16.12 1PLG PLG 2.8A/16.4% Anti-alpha-(2->8)-polysialic acid 16.7.9.5.17.8 1PSK ME36 2.8/20.4% Fab that binds melanoma-associated GD2 ganglioside 10.7.9.5.17.5 1REI REI 2.0A/???? Light chain dimer 11.7.9 1RMF R6.5 2.8A/18.8% Anti-ICAM-1 16.7.9.5.17.10 1TET TE33 2.3A/14.8% Complex with cholera toxin peptide 3 16.7.9.5.17.7 1UCB BR96 2.5/20% Free Fab, chimeric, anti-Lewis Y antigen 16.7.9.5.17.10 1VFA D1.3 1.8A/15.8% Anti-lysozyme (uncomplexed) 11.7.9.5.16.8 1VGE TR1.9 2.0/18.0% Anti-Thyroid Peroxidase Human-Auto-Ab. Insert at H4A 11.7.9.5.17.12 1VHP VH-P8 NMR Camelised human antibody VH domain 0.0.0.5.17.8 1WTL WAT 1.9A/15.7% Light chain dimer 11.7.9 1YEC D2.3 1.9/20.8% Catalytic antibody 16.7.9.5.17.14 1YUH 88C6/12 3.0/19.0% Complex with 4-Hydroxy-3-Nitrophenylacetic Acid 14.7.9.5.17.9 2CGR cgs/cgr 2.2A/21.4% Complex with hapten 16.7.9.5.17.7 2FB4 Kol 1.9A/18.9% Myeloma FAB 13.7.11.5.17.17 2FBJ J539 1.95A/19.4% Complex with galactan 10.7.9.5.17.9 2GFB CNJ206 3.0A/21.3% Catalytic (Esterase) 11.7.9.5.17.10 2H1P 2H1 2.40A/18.6% Complex with peptide 16.7.9.5.17.11 2HRP F11.2.32 2.20/19.80% Complex with HIV1 protease-peptide 15.7.9.5.17.16 2MCG MCG 2.0A/18.7% Light chain dimer 14.7.10 2RHE RHE 1.6A/14.9% Light chain dimer 13.7.11 3HFL HyHEL-5 2.65A/19.6% Complex with hen egg lysozyme 10.7.8.5.17.7 3HFM HyHEL-10 3.0A/24.6% Complex with hen egg lysozyme 11.7.9.5.16.5 6FAB 36-71 1.9A/20.9% Anti-phenylarsonate 11.7.9.5.17.12 7FAB New 2.0A/16.9% ?????? 14.4.9.5.16.9 8FAB Hil 1.8A/17.3% Human myeloma 11.7.9.5.17.12